Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
S&W Seed Co | Director | Common Stock | 152K | $80.2K | $0.53 | Dec 15, 2023 | Direct |
Ovid Therapeutics Inc. | CBFO | Common Stock | 28.1K | $60.5K | $2.15 | Feb 22, 2024 | Direct |
Ovid Therapeutics Inc. | CBFO | Employee Stock Option (right to buy) | 315K | Jul 30, 2024 | Direct | ||
Ovid Therapeutics Inc. | CBFO | Stock Option (Right to Buy) | 0 | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Jul 30, 2024 | 1 | $0 | 4 | Aug 1, 2024 | CBFO |
OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | CBFO |
SANW | S&W Seed Co | Dec 15, 2023 | 1 | $0 | 4 | Dec 19, 2023 | Director |
SANW | S&W Seed Co | Dec 15, 2023 | 0 | $0 | 3 | Dec 19, 2023 | Director |
OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | CBFO |
OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 2 | $0 | 4 | Apr 12, 2022 | CBFO |
OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | CBFO |
OVID | Ovid Therapeutics Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Chief Business Officer |